Repligen Corp (NAS:RGEN)
$ 168.03 -3.75 (-2.18%) Market Cap: 9.39 Bil Enterprise Value: 9.57 Bil PE Ratio: 672.12 PB Ratio: 4.76 GF Score: 93/100

Repligen Corp at William Blair Growth Stock Conference Transcript

Jun 08, 2023 / 04:20PM GMT
Release Date Price: $164.23 (-4.97%)
Matthew Richard Larew
William Blair & Company L.L.C., Research Division - Research Analyst & Partner

(technical difficulty) [Tony] Hunt for joining us here in nearly the conclusion of this year's conference and very happy to have once again, Repligen here with us today. CEO, Tony Hunt, is here with us; and Sondra Newman from IR as well. So thank you both for being here. Just briefly 2 things. There will be a breakout session in Maher, on the second floor after this presentation, you can follow us up. And then second for a complete list of research and disclosures, please go to williamblair.com. So again, thank you very much to Repligen for joining us.

And Tony, I'll turn it over to you.

Anthony J. Hunt
Repligen Corporation - President, CEO & Director

Thanks, Matt. Appreciate it. Hey, it's great to be here, and it's also good to close out the conference. It's -- maybe before I jump into the presentation, maybe a couple of comments on the bioprocessing industry. I think everybody knows it's been a more challenging year for our industry

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot